Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Mirkin

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Menopause (New York, N.Y.)|May 11, 2016
Conjugated estrogens and bazedoxifene in minority populations: pooled analysis of four phase 3 trialsJoAnn V Pinkerton, James H Pickar, Kelly A Ryan, et al.
Menopause (New York, N.Y.)|December 24, 2015
The effect of conjugated estrogens/bazedoxifene therapy on body weight of postmenopausal women: pooled analysis of five randomized, placebo-controlled trialsDenise Black, Michael Messig, Ching-Ray Yu, et al.
Menopause (New York, N.Y.)|April 19, 2017
Visual improvements in vaginal mucosa correlate with symptoms of VVA: data from a double-blind, placebo-controlled trialJames A Simon, David F Archer, Risa Kagan, et al.
Menopause (New York, N.Y.)|October 31, 2019
Physical characteristics and properties of estradiol softgel vaginal insertsJames A Simon, James H Pickar, Annette M Shadiack, et al.
Journal of Women'S Health (2002)|March 30, 2017
Consistency of Effect with a Low-Dose, Estradiol Vaginal Capsule (TX-004HR): Evaluating Improvement in Vaginal Physiology and Moderate-to-Severe Dyspareunia in Subgroups of Postmenopausal WomenGinger D Constantine, Celine Bouchard, James H Pickar, et al.
Menopause (New York, N.Y.)|December 6, 2018
Evaluation of clinical meaningfulness of estrogen plus progesterone oral capsule (TX-001HR) on moderate to severe vasomotor symptomsGinger D Constantine, Dennis A Revicki, Risa Kagan, et al.
The Journal of Clinical Endocrinology and Metabolism|January 21, 2014
Effects of bazedoxifene/conjugated estrogens on the endometrium and bone: a randomized trialJoann V Pinkerton, Jennifer A Harvey, Robert Lindsay, et al.
Current Medical Research and Opinion|September 22, 2018
Estradiol vaginal inserts (4 µg and 10 µg) for treating moderate to severe vulvar and vaginal atrophy: a review of phase 3 safety, efficacy and pharmacokinetic dataGinger D Constantine, James A Simon, James H Pickar, et al.
Menopause (New York, N.Y.)|July 19, 2017
In ReplyDavid F Archer, Ginger D Constantine, James Simon, et al.
Menopause (New York, N.Y.)|February 15, 2017
Patient acceptability and satisfaction with a low-dose solubilized vaginal estradiol softgel capsule, TX-004HRSheryl A Kingsberg, Robin Kroll, Irwin Goldstein, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Menopause (New York, N.Y.)|May 11, 2016
Conjugated estrogens and bazedoxifene in minority populations: pooled analysis of four phase 3 trialsJoAnn V Pinkerton, James H Pickar, Kelly A Ryan, et al.
Menopause (New York, N.Y.)|December 24, 2015
The effect of conjugated estrogens/bazedoxifene therapy on body weight of postmenopausal women: pooled analysis of five randomized, placebo-controlled trialsDenise Black, Michael Messig, Ching-Ray Yu, et al.
Menopause (New York, N.Y.)|April 19, 2017
Visual improvements in vaginal mucosa correlate with symptoms of VVA: data from a double-blind, placebo-controlled trialJames A Simon, David F Archer, Risa Kagan, et al.
Menopause (New York, N.Y.)|October 31, 2019
Physical characteristics and properties of estradiol softgel vaginal insertsJames A Simon, James H Pickar, Annette M Shadiack, et al.
Journal of Women'S Health (2002)|March 30, 2017
Consistency of Effect with a Low-Dose, Estradiol Vaginal Capsule (TX-004HR): Evaluating Improvement in Vaginal Physiology and Moderate-to-Severe Dyspareunia in Subgroups of Postmenopausal WomenGinger D Constantine, Celine Bouchard, James H Pickar, et al.
Menopause (New York, N.Y.)|December 6, 2018
Evaluation of clinical meaningfulness of estrogen plus progesterone oral capsule (TX-001HR) on moderate to severe vasomotor symptomsGinger D Constantine, Dennis A Revicki, Risa Kagan, et al.
The Journal of Clinical Endocrinology and Metabolism|January 21, 2014
Effects of bazedoxifene/conjugated estrogens on the endometrium and bone: a randomized trialJoann V Pinkerton, Jennifer A Harvey, Robert Lindsay, et al.
Current Medical Research and Opinion|September 22, 2018
Estradiol vaginal inserts (4 µg and 10 µg) for treating moderate to severe vulvar and vaginal atrophy: a review of phase 3 safety, efficacy and pharmacokinetic dataGinger D Constantine, James A Simon, James H Pickar, et al.
Menopause (New York, N.Y.)|July 19, 2017
In ReplyDavid F Archer, Ginger D Constantine, James Simon, et al.
Menopause (New York, N.Y.)|February 15, 2017
Patient acceptability and satisfaction with a low-dose solubilized vaginal estradiol softgel capsule, TX-004HRSheryl A Kingsberg, Robin Kroll, Irwin Goldstein, et al.
Pageof 11